Rocuronium vs Succinylcholine for Anesthesia
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the drugs Rocuronium and Succinylcholine for anesthesia?
Research suggests that Rocuronium can be an effective alternative to Succinylcholine for rapid-sequence induction of anesthesia, as it has a quick onset of action and lacks some of the adverse reactions associated with Succinylcholine. Additionally, Rocuronium, when used with Sugammadex, may offer benefits in time to tracheal intubation during cesarean delivery compared to Succinylcholine.12345
Is it safe to use Rocuronium or Succinylcholine for anesthesia?
How do the drugs rocuronium and succinylcholine differ for anesthesia?
Rocuronium and succinylcholine are both used for rapid-sequence intubation during anesthesia, but rocuronium is a nondepolarizing muscle relaxant that avoids the adverse reactions associated with succinylcholine. Additionally, rocuronium can be reversed with sugammadex, offering a unique advantage in certain situations.23479
What is the purpose of this trial?
The purpose of this study is to assess and compare conditions for tracheal intubation obtained with modified time principal induction with 0.6 mg/kg rocuronium and 1 mg/kg succinylcholine. Specifically, the investigators will be evaluating ease of laryngoscopy, vocal cord view, vocal cord opening, and movement of limbs and coughing during tracheal intubation in order to assess intubation conditions, to compare efficiency and success rate of tracheal intubation between two induction agents and to determine the rate of patient awareness during induction and post-operative recall of paralysis.
Research Team
Lauren M Nakazawa, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Eligibility Criteria
This trial is for adults needing general anesthesia and intubation, with a BMI over 30 or a Mallampati score of III/IV. It's not for those allergic to certain anesthetics, pregnant women, people with severe health issues (ASA > III), renal failure with high potassium levels, respiratory disorders like COPD/asthma, untreated heart disease, history of malignant hyperthermia or neuromuscular diseases.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Induction and Intubation
Participants undergo rapid sequence induction and tracheal intubation using either rocuronium or succinylcholine. Conditions such as ease of laryngoscopy, vocal cord view, and movement during intubation are assessed.
Post-operative Monitoring
Participants are monitored for post-operative recall of paralysis, injury associated with intubation, and overall satisfaction within 24 hours after surgery.
Follow-up
Participants are monitored for any delayed adverse effects and overall satisfaction with the procedure.
Treatment Details
Interventions
- Rocuronium
- Succinylcholine
Rocuronium is already approved in United States, European Union, Canada, Japan for the following indications:
- Endotracheal intubation
- Mechanical ventilation
- Surgical procedures requiring neuromuscular blockade
- Endotracheal intubation
- Mechanical ventilation
- Surgical procedures requiring neuromuscular blockade
- Endotracheal intubation
- Mechanical ventilation
- Surgical procedures requiring neuromuscular blockade
- Endotracheal intubation
- Mechanical ventilation
- Surgical procedures requiring neuromuscular blockade
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor